 | • レポートコード：QYR9ST03884 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、因子IX欠乏症の治療の世界市場について調査・分析し、因子IX欠乏症の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（血友病B、血友病B阻害剤）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の因子IX欠乏症の治療市場動向 ・主要企業別マーケットシェア ・因子IX欠乏症の治療の種類別市場規模2014-2019 （血友病B、血友病B阻害剤） ・因子IX欠乏症の治療の用途別市場規模2014-2019 （病院、診療所、その他） ・因子IX欠乏症の治療の北米市場：主要企業・種類別/用途別市場規模 ・因子IX欠乏症の治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・因子IX欠乏症の治療の中国市場：主要企業・種類別/用途別市場規模 ・因子IX欠乏症の治療の日本国内市場：主要企業・種類別/用途別市場規模 ・因子IX欠乏症の治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・因子IX欠乏症の治療のインド市場：主要企業・種類別/用途別市場規模 ・因子IX欠乏症の治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Shire、Novo Nordisk、Biogen、CSL Behring） ・因子IX欠乏症の治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B.In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market during the forecast period. Factors such a low cost and high efficiency are the key contributors to the dominance of this segment in the global market.
The global hemophilia B drugs market is expected to grow at a moderate pace during the forecast period. The growing incidence of hemophilia B is expected to drive the market growth. Also, the increasing demand for novel recombinant extended half-life products coupled with the emergence of monoclonal antibodies and gene therapy products will propel the growth of this segment in the next few years.
In 2018, the global Factor IX Deficiency Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Factor IX Deficiency Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Factor IX Deficiency Treatment development in United States, Europe and China.
The key players covered in this study
Pfizer
Shire
Novo Nordisk
Biogen
CSL Behring
…
Market segment by Type, the product can be split into
Hemophilia B
Hemophilia B Inhibitors
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Factor IX Deficiency Treatment status, future forecast, growth opportunity, key market and key players.
To present the Factor IX Deficiency Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Factor IX Deficiency Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Factor IX Deficiency Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Hemophilia B
1.4.3 Hemophilia B Inhibitors
1.5 Market by Application
1.5.1 Global Factor IX Deficiency Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Factor IX Deficiency Treatment Market Size
2.2 Factor IX Deficiency Treatment Growth Trends by Regions
2.2.1 Factor IX Deficiency Treatment Market Size by Regions (2014-2025)
2.2.2 Factor IX Deficiency Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Factor IX Deficiency Treatment Market Size by Manufacturers
3.1.1 Global Factor IX Deficiency Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Factor IX Deficiency Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Factor IX Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Factor IX Deficiency Treatment Key Players Head office and Area Served
3.3 Key Players Factor IX Deficiency Treatment Product/Solution/Service
3.4 Date of Enter into Factor IX Deficiency Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Factor IX Deficiency Treatment Market Size by Type (2014-2019)
4.2 Global Factor IX Deficiency Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Factor IX Deficiency Treatment Market Size (2014-2019)
5.2 Factor IX Deficiency Treatment Key Players in United States
5.3 United States Factor IX Deficiency Treatment Market Size by Type
5.4 United States Factor IX Deficiency Treatment Market Size by Application
6 Europe
6.1 Europe Factor IX Deficiency Treatment Market Size (2014-2019)
6.2 Factor IX Deficiency Treatment Key Players in Europe
6.3 Europe Factor IX Deficiency Treatment Market Size by Type
6.4 Europe Factor IX Deficiency Treatment Market Size by Application
7 China
7.1 China Factor IX Deficiency Treatment Market Size (2014-2019)
7.2 Factor IX Deficiency Treatment Key Players in China
7.3 China Factor IX Deficiency Treatment Market Size by Type
7.4 China Factor IX Deficiency Treatment Market Size by Application
8 Japan
8.1 Japan Factor IX Deficiency Treatment Market Size (2014-2019)
8.2 Factor IX Deficiency Treatment Key Players in Japan
8.3 Japan Factor IX Deficiency Treatment Market Size by Type
8.4 Japan Factor IX Deficiency Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Factor IX Deficiency Treatment Market Size (2014-2019)
9.2 Factor IX Deficiency Treatment Key Players in Southeast Asia
9.3 Southeast Asia Factor IX Deficiency Treatment Market Size by Type
9.4 Southeast Asia Factor IX Deficiency Treatment Market Size by Application
10 India
10.1 India Factor IX Deficiency Treatment Market Size (2014-2019)
10.2 Factor IX Deficiency Treatment Key Players in India
10.3 India Factor IX Deficiency Treatment Market Size by Type
10.4 India Factor IX Deficiency Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Factor IX Deficiency Treatment Market Size (2014-2019)
11.2 Factor IX Deficiency Treatment Key Players in Central & South America
11.3 Central & South America Factor IX Deficiency Treatment Market Size by Type
11.4 Central & South America Factor IX Deficiency Treatment Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Factor IX Deficiency Treatment Introduction
12.1.4 Pfizer Revenue in Factor IX Deficiency Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Shire
12.2.1 Shire Company Details
12.2.2 Company Description and Business Overview
12.2.3 Factor IX Deficiency Treatment Introduction
12.2.4 Shire Revenue in Factor IX Deficiency Treatment Business (2014-2019)
12.2.5 Shire Recent Development
12.3 Novo Nordisk
12.3.1 Novo Nordisk Company Details
12.3.2 Company Description and Business Overview
12.3.3 Factor IX Deficiency Treatment Introduction
12.3.4 Novo Nordisk Revenue in Factor IX Deficiency Treatment Business (2014-2019)
12.3.5 Novo Nordisk Recent Development
12.4 Biogen
12.4.1 Biogen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Factor IX Deficiency Treatment Introduction
12.4.4 Biogen Revenue in Factor IX Deficiency Treatment Business (2014-2019)
12.4.5 Biogen Recent Development
12.5 CSL Behring
12.5.1 CSL Behring Company Details
12.5.2 Company Description and Business Overview
12.5.3 Factor IX Deficiency Treatment Introduction
12.5.4 CSL Behring Revenue in Factor IX Deficiency Treatment Business (2014-2019)
12.5.5 CSL Behring Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Factor IX Deficiency Treatment Key Market Segments
Table Key Players Factor IX Deficiency Treatment Covered
Table Global Factor IX Deficiency Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Factor IX Deficiency Treatment Market Size Market Share by Type 2014-2025
Figure Hemophilia B Figures
Table Key Players of Hemophilia B
Figure Hemophilia B Inhibitors Figures
Table Key Players of Hemophilia B Inhibitors
Table Global Factor IX Deficiency Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Factor IX Deficiency Treatment Report Years Considered
Table Global Factor IX Deficiency Treatment Market Size 2014-2025 (Million US$)
Figure Global Factor IX Deficiency Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Factor IX Deficiency Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Factor IX Deficiency Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Factor IX Deficiency Treatment Market Share by Regions 2014-2019
Figure Global Factor IX Deficiency Treatment Market Share by Regions 2014-2019
Figure Global Factor IX Deficiency Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Factor IX Deficiency Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Factor IX Deficiency Treatment Market Share by Manufacturers (2014-2019)
Figure Global Factor IX Deficiency Treatment Market Share by Manufacturers in 2018
Table Global Factor IX Deficiency Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Factor IX Deficiency Treatment Product/Solution/Service
Table Date of Enter into Factor IX Deficiency Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Factor IX Deficiency Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Factor IX Deficiency Treatment Market Size Share by Type (2014-2019)
Figure Global Factor IX Deficiency Treatment Market Size Market Share by Type (2014-2019)
Table Global Factor IX Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Factor IX Deficiency Treatment Market Size Share by Application (2014-2019)
Figure Global Factor IX Deficiency Treatment Market Size Market Share by Application (2014-2019)
Figure Global Factor IX Deficiency Treatment Revenue Market Share by Application in 2018
Figure United States Factor IX Deficiency Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Factor IX Deficiency Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Factor IX Deficiency Treatment Market Share (2018-2019)
Table United States Factor IX Deficiency Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Factor IX Deficiency Treatment Market Share by Type (2014-2019)
Table United States Factor IX Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Factor IX Deficiency Treatment Market Share by Application (2014-2019)
Figure Europe Factor IX Deficiency Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Factor IX Deficiency Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Factor IX Deficiency Treatment Market Share (2018-2019)
Table Europe Factor IX Deficiency Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Factor IX Deficiency Treatment Market Share by Type (2014-2019)
Table Europe Factor IX Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Factor IX Deficiency Treatment Market Share by Application (2014-2019)
Figure China Factor IX Deficiency Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Factor IX Deficiency Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Factor IX Deficiency Treatment Market Share (2018-2019)
Table China Factor IX Deficiency Treatment Market Size by Type (2014-20189) (Million US$)
Table China Factor IX Deficiency Treatment Market Share by Type (2014-2019)
Table China Factor IX Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table China Factor IX Deficiency Treatment Market Share by Application (2014-2019)
Figure Japan Factor IX Deficiency Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Factor IX Deficiency Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Factor IX Deficiency Treatment Market Share (2018-2019)
Table Japan Factor IX Deficiency Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Factor IX Deficiency Treatment Market Share by Type (2014-2019)
Table Japan Factor IX Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Factor IX Deficiency Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Factor IX Deficiency Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Factor IX Deficiency Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Factor IX Deficiency Treatment Market Share (2018-2019)
Table Southeast Asia Factor IX Deficiency Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Factor IX Deficiency Treatment Market Share by Type (2014-2019)
Table Southeast Asia Factor IX Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Factor IX Deficiency Treatment Market Share by Application (2014-2019)
Figure India Factor IX Deficiency Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Factor IX Deficiency Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Factor IX Deficiency Treatment Market Share (2018-2019)
Table India Factor IX Deficiency Treatment Market Size by Type (2014-2019) (Million US$)
Table India Factor IX Deficiency Treatment Market Share by Type (2014-2019)
Table India Factor IX Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table India Factor IX Deficiency Treatment Market Share by Application (2014-2019)
Figure Central & South America Factor IX Deficiency Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Factor IX Deficiency Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Factor IX Deficiency Treatment Market Share (2018-2019)
Table Central & South America Factor IX Deficiency Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Factor IX Deficiency Treatment Market Share by Type (2014-2019)
Table Central & South America Factor IX Deficiency Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Factor IX Deficiency Treatment Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Factor IX Deficiency Treatment Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Factor IX Deficiency Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Shire Company Details
Table Shire Revenue in Factor IX Deficiency Treatment Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Factor IX Deficiency Treatment Business (2014-2019)
Table Shire Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Factor IX Deficiency Treatment Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Factor IX Deficiency Treatment Business (2014-2019)
Table Novo Nordisk Recent Development
Table Biogen Company Details
Table Biogen Revenue in Factor IX Deficiency Treatment Business (2014-2019)(Million US$)
Figure Biogen Revenue Growth Rate in Factor IX Deficiency Treatment Business (2014-2019)
Table Biogen Recent Development
Table CSL Behring Company Details
Table CSL Behring Revenue in Factor IX Deficiency Treatment Business (2014-2019)(Million US$)
Figure CSL Behring Revenue Growth Rate in Factor IX Deficiency Treatment Business (2014-2019)
Table CSL Behring Recent Development
Table Global Factor IX Deficiency Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Factor IX Deficiency Treatment Market Size Share by Regions (2019-2025)
Figure Global Factor IX Deficiency Treatment Market Size Share by Regions in 2025
Figure United States Factor IX Deficiency Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Factor IX Deficiency Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Factor IX Deficiency Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Factor IX Deficiency Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Factor IX Deficiency Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Factor IX Deficiency Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Factor IX Deficiency Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Factor IX Deficiency Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Factor IX Deficiency Treatment Market Size by Product (2019-2025)
Figure Global Factor IX Deficiency Treatment Market Size by Product in 2025
Table Global Factor IX Deficiency Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Factor IX Deficiency Treatment Market Size by Application (2019-2025)
Figure Global Factor IX Deficiency Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
第VIII因子欠乏症の治療の世界市場：市場規模・現状・予測 Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endotheli…- 血友病A及びB組換え因子補充療法の世界市場：市場規模・現状・予測 Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…
- 成長ホルモン欠乏症治療の世界市場：市場規模・現状・予測 Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction.The primary factor contributing to the growth of global growth hormone deficien…
- チロシンヒドロキシラーゼ欠乏症の世界市場：市場規模・現状・予測 The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…
- 血友病治療薬の世界市場：市場規模・現状・予測 Hemophilia is a rare, inherited disorder in which blood doesn’t clot normally due to the lack of sufficient blood clotting factor. Clotting factor is a protein required for blood clotting to occur normally. These proteins work with platelets i.e. small blood cell fragments that form in the bone marr…